References
- Franciosa JA, Wilen M, Ziesche S, et al. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983: 51(5): 831–6
- Franciosa J A, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1979: 47(1): 33–9
- Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration cooperative study. N Engl J Med 1986: 314(24): 1547–52
- Spann JF Jr. Boccino RA, Sonnenblick EH, et al. Contractile state of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy and heart failure. Circ Res 1967: 21(3): 341–54
- Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 1982: 307(4): 205–11
- Cohn JN, Franciosa JA. Vasodilator therapy of cardiac failure. N Engl J Med 1977: 297(1): 27–31; 297(5): 254–8
- Zelis R, Flaim SF. Alterations in vasomotor tone in congestive heart failure. Prog Candiovasc Dis 1982: 24(6): 437–59
- Francis GS, Goldsmith SR, Levine TB, et al. The neurohumoral axis in congestive heart failure. Ann Intern Med 1984: 101(3): 370–7
- Leler CV, Heban PT, Huss P. et al. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation 1978: 58: 466–73
- Fleg JL, Gottlieb SH, Lakatta EG. Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm. AM J Med 1982: 73(2): 244–50
- Lee DC, Johnson RA, Bingham JB, et al. Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med 1982: 306(12): 699–705
- Miller RR, Fennell WH, Young JB, et al. Differential systemic arterial and venous actions and consequent cardiac effects of vasodilator drugs. Prog Cardiovasc Dis 1982: 24(5): 353–74
- Franciosa JA. Goldsmith SR, Cohn JN. Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure. Am J Med 1980: 69(4): 559–66
- Franciosa JA, Weber KT, Levine TB, et al. Hydralizine in the long-term treatment of chronic heart failure: lack of difference from placebo. Am Heart J 1982: 104(3): 587–94
- Packer M, Meller J, Gorlin R, et al. Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe congestive heart failure. Circulation 1979: 59(3): 531–9
- Levine TB, Granciosa JA, Cohn JN. Acute and long-term response to an oral converting-enzyme inhibitor, Captopril. in congestive heart failure. Circulation 1980: 62(1): 35–41
- Cody RJ, Covit AB, Schaer GL, et al. Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure. J Am Coll Cardiol 1983: 1(4): 1154–9
- Packer M. Lee WH, Kessler PD. Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system. Circulation 1986: 74(4): 766–74
- Swedberg K, Hjalmarson A. wasgstein FH, et al. Beneficial effects on long-term beta-blockade in congestive cardiomyopathy. Br Heart J 1980: 44(2): 117–33
- Engelmeier RS, O'Connell JB, Walsh R, et al. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. Circulation 1985: 72(3): 536–46
- Copeland JG, Emery RW, Levinson MN, et al. Selection of patients for cardiac transplantation. Circulation 1987: 75(1): 2–9